OrthoPediatrics Corp. (KIDS)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
OrthoPediatrics Corp. (KIDS) trades at $20.39 with AI Score 36/100 (Grade D). OrthoPediatrics Corp. focuses on designing, developing, and marketing orthopedic implants and devices specifically for children. Market cap: $523.72M, Sector: Healthcare.
Price live · AI analysis from May 7, 2026KIDS stock analysis for 2026: Analysts have set a consensus price target of $25.00 for OrthoPediatrics Corp., suggesting 22.6% upside from the current price of $20.39. The AI MoonshotScore is 36/100, indicating a bearish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.
KIDS: 1/1 perspectives are bearish.
How is this calculated? →OrthoPediatrics Corp. (KIDS) Healthcare & Pipeline Overview
OrthoPediatrics Corp. specializes in pediatric orthopedic solutions, offering a range of implants and devices tailored for children's unique anatomical needs. With a focus on trauma, deformity correction, scoliosis, and sports medicine, the company serves a niche market within the broader medical device industry, primarily in the United States and internationally.
What Is the Investment Thesis for KIDS?
OrthoPediatrics Corp. presents a focused investment opportunity within the niche market of pediatric orthopedics. The company's dedication to anatomically appropriate implants and devices differentiates it from competitors, positioning it as a key player in this specialized field. With a gross margin of 73.1%, OrthoPediatrics demonstrates strong pricing power and efficient operations. The company's growth is driven by increasing awareness of pediatric-specific orthopedic needs and expanding its product portfolio. Key value drivers include continued innovation in product design, expansion into new geographic markets, and strategic partnerships with pediatric orthopedic surgeons. Upcoming catalysts include the launch of new products and expansion of the sales force. Potential risks include competition from larger medical device companies and regulatory hurdles. Despite a negative profit margin of -16.3%, the company's revenue growth and market leadership in pediatric orthopedics make it an attractive investment for those seeking exposure to the healthcare sector.
Based on FMP financials and quantitative analysis
KIDS Key Highlights
- OrthoPediatrics focuses exclusively on the pediatric orthopedic market, a niche with specific anatomical needs.
- Gross margin of 73.1% indicates strong pricing power and efficient operations.
- Comprehensive product portfolio includes solutions for trauma, deformity correction, scoliosis, and sports medicine.
- Serves pediatric orthopedic surgeons and caregivers in the United States and internationally.
- Founded in 2006, the company has established itself as a key player in the pediatric orthopedic market.
Who Are KIDS's Competitors?
KIDS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| JNJ Johnson & Johnson | $258.13 | -1.87% | $621.38B | 90 |
| BSX Boston Scientific Corporation | $44.60 | -1.20% | 67B | 82 |
| ZBH Zimmer Biomet Holdings, Inc. | $89.68 | +2.53% | $17.35B | 79 |
| DCTH Delcath Systems, Inc. | $13.61 | +3.11% | $469.84M | 73 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $0.20 | +3.40% | $18.68M | 73 |
| SSII SS Innovations International, Inc. | $3.76 | -0.53% | $752.49M | 72 |
| RSHUF Respiri Limited | $0.06 | +0.00% | $91.52M | 68 |
| EW Edwards Lifesciences Corporation | $95.44 | +1.14% | $54.96B | 58 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are KIDS's Key Strengths?
- Focus on a niche market with unmet needs
- Specialized expertise in pediatric orthopedics
- Comprehensive product portfolio
- Strong relationships with pediatric orthopedic surgeons
What Are KIDS's Weaknesses?
- Smaller size compared to larger medical device companies
- Negative profit margin
- Limited geographic reach
- Dependence on a single market segment
What Could Drive KIDS Stock Higher?
- Launch of new orthopedic implants designed for pediatric patients.
- Expansion of the sales force to increase market penetration.
- Strategic partnerships with leading pediatric orthopedic surgeons.
- Increasing awareness of pediatric-specific orthopedic needs.
What Are the Key Risks for KIDS?
- Negative return on equity (-11.4%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Competition from larger medical device companies with greater resources.
- Regulatory hurdles and product approval delays.
- Product liability claims related to orthopedic implants.
- Economic downturns affecting hospital budgets and patient spending.
What Are the Growth Opportunities for KIDS?
- Expansion into new geographic markets represents a significant growth opportunity for OrthoPediatrics. Currently, the company operates primarily in the United States, with some international presence. Expanding into Europe, Asia, and Latin America could significantly increase revenue. The global orthopedic device market is estimated to reach $60 billion by 2028, providing ample opportunity for OrthoPediatrics to gain market share in new regions. Timeline: Ongoing.
- Development of new products and technologies is crucial for maintaining a competitive edge. OrthoPediatrics can invest in research and development to create innovative implants and devices that address unmet needs in pediatric orthopedics. For example, the company could develop new minimally invasive surgical techniques or bioresorbable implants. The market for advanced orthopedic technologies is growing rapidly, driven by demand for improved patient outcomes. Timeline: Ongoing.
- Strategic partnerships with pediatric orthopedic surgeons can enhance OrthoPediatrics' market position. By collaborating with leading surgeons, the company can gain valuable insights into clinical needs and develop products that meet those needs. These partnerships can also help OrthoPediatrics expand its reach and build brand awareness. The pediatric orthopedic community is relatively small, making these relationships particularly valuable. Timeline: Ongoing.
- Increasing awareness of pediatric-specific orthopedic needs is driving demand for OrthoPediatrics' products. As more healthcare providers and parents recognize the importance of using implants and devices designed specifically for children, the company's market share is likely to increase. OrthoPediatrics can further promote this awareness through educational programs and marketing campaigns. The market for pediatric orthopedic devices is estimated to be worth $2 billion. Timeline: Ongoing.
- Acquisition of complementary businesses or technologies can accelerate OrthoPediatrics' growth. The company could acquire smaller companies with innovative products or technologies that would expand its product portfolio or geographic reach. This strategy can provide access to new markets and customers, as well as synergies that improve efficiency and profitability. The medical device industry is highly fragmented, providing numerous acquisition opportunities. Timeline: Ongoing.
What Opportunities Does KIDS Have?
- Expansion into new geographic markets
- Development of new products and technologies
- Strategic partnerships with pediatric orthopedic surgeons
- Increasing awareness of pediatric-specific orthopedic needs
What Threats Does KIDS Face?
- Competition from larger medical device companies
- Regulatory hurdles
- Product liability claims
- Economic downturns
What Are KIDS's Competitive Advantages?
- Specialized expertise in pediatric orthopedics
- Proprietary designs and technologies
- Strong relationships with pediatric orthopedic surgeons
- High barriers to entry due to regulatory requirements and specialized knowledge
What Does KIDS Do?
Founded in 2006 and headquartered in Warsaw, Indiana, OrthoPediatrics Corp. emerged to address the unmet needs in pediatric orthopedics. Recognizing that children's anatomies differ significantly from adults, the company dedicated itself to designing and manufacturing implants and devices specifically for young patients. This focus distinguishes OrthoPediatrics from larger medical device companies that often adapt adult products for pediatric use. The company's product portfolio includes a comprehensive range of solutions for trauma and deformity correction, scoliosis treatment, and sports medicine. Key products include PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, and PediLoc tibia. For scoliosis, OrthoPediatrics offers RESPONSE Spine systems and ApiFix Mid-C system. In sports medicine, the company provides anterior cruciate ligament reconstruction systems. Additional products include locking cannulated blades, locking proximal femurs, Spica Tables, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, and QuickPack. OrthoPediatrics serves pediatric orthopedic surgeons and caregivers in the United States and internationally. The company's commitment to innovation and anatomically appropriate designs has established it as a key player in the pediatric orthopedic market. By focusing solely on children, OrthoPediatrics has developed specialized expertise and a deep understanding of the unique challenges in this field. The company continues to expand its product offerings and geographic reach to improve the lives of children with orthopedic conditions.
What Products and Services Does KIDS Offer?
- Designs anatomically appropriate implants and devices for children with orthopedic conditions.
- Offers trauma and deformity correction products.
- Provides scoliosis procedures for the treatment of spinal deformity.
- Develops sports medicine products for pediatric patients.
- Markets its products to pediatric orthopedic surgeons and caregivers.
- Focuses on innovation and specialized expertise in pediatric orthopedics.
How Does KIDS Make Money?
- Designs and manufactures orthopedic implants and devices specifically for children.
- Sells its products directly to hospitals and orthopedic surgeons.
- Generates revenue through product sales in the United States and internationally.
- Invests in research and development to create new and innovative products.
What Industry Does KIDS Operate In?
The medical device industry is characterized by constant innovation and regulatory scrutiny. OrthoPediatrics operates within the pediatric orthopedic segment, a niche market that is growing due to increased awareness of the unique needs of children. The company competes with larger medical device companies that may offer some pediatric products, but OrthoPediatrics' exclusive focus provides a competitive advantage. The global orthopedic device market is expected to continue growing, driven by an aging population and increasing demand for minimally invasive procedures. OrthoPediatrics is well-positioned to capitalize on this trend by expanding its product offerings and geographic reach.
Who Are KIDS's Key Customers?
- Pediatric orthopedic surgeons
- Hospitals and medical centers
- Caregivers of children with orthopedic conditions
FY2026 estForward Outlook
Wall Street analysts project OrthoPediatrics Corp. revenue of about $265.2M for fiscal 2026, with EPS near $-1.18. The estimate reflects 6 contributing analysts.
ROE -11%Key Financial Metrics
Return on equity for OrthoPediatrics Corp. stands at -11.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -7.9%, showing how much profit it generates from its asset base. Its free cash flow yield is -2.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 5.21 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -8.6%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 3/9Financial Health
OrthoPediatrics Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 1.90 places it in the grey zone, a middle ground that warrants monitoring.
KIDS Valuation & Market Position
With a $523.72M market cap, OrthoPediatrics Corp. sits in the small-cap segment of the market. Relative to its peer group, KIDS's quantitative score of 36/100 is below the peer average of 79/100.
KIDS Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's growth potential, indicating that executives believe in the future of OrthoPediatrics.
- Community sentiment has shifted positively, with discussions highlighting the company's innovative product pipeline in pediatric orthopedic solutions.
- Analysts and traders are optimistic about the increasing demand for specialized pediatric care, which aligns with OrthoPediatrics' focus.
- Recent partnerships and collaborations have strengthened the company's market position, enhancing its credibility and attractiveness to investors.
Bear Case
- Concerns around regulatory challenges in the medical device industry have emerged, potentially impacting future product launches.
- Social sentiment has shown some skepticism regarding the company's ability to scale operations effectively in a competitive market.
- Recent earnings reports have raised questions about profitability, with some community members expressing doubts about sustainable growth.
- Market perception has been tempered by broader economic uncertainties affecting healthcare spending, leading to a cautious outlook.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
KIDS Latest News
-
NYSE President Lynn Martin Joins U.S. Presidential Delegation for Historic Trump-Xi China Summit in Beijing
gurufocus.com · May 15, 2026
-
Is the Selloff in OrthoPediatrics Corp. (KIDS) Creating a Buying Opportunity?
Yahoo! Finance: KIDS News · May 13, 2026
-
Earnings Scheduled For April 30, 2026
benzinga · Apr 30, 2026
-
Earnings Scheduled For February 26, 2026
benzinga · Feb 26, 2026
KIDS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for KIDS.
Price Targets
Consensus target: $25.00
KIDS MoonshotScore
What does this score mean?
The MoonshotScore rates KIDS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
NYSE President Lynn Martin Joins U.S. Presidential Delegation for Historic Trump-Xi China Summit in Beijing
Is the Selloff in OrthoPediatrics Corp. (KIDS) Creating a Buying Opportunity?
Earnings Scheduled For April 30, 2026
Earnings Scheduled For February 26, 2026
Leadership: David R. Bailey
CEO
David R. Bailey serves as the Chief Executive Officer of OrthoPediatrics Corp. His career reflects a deep understanding of the medical device industry, with extensive experience in leadership roles. He has a proven track record of driving growth and innovation within the healthcare sector. His expertise encompasses strategic planning, product development, and market expansion. He is responsible for managing the company's overall direction and ensuring its continued success in the pediatric orthopedic market.
Track Record: Under David R. Bailey's leadership, OrthoPediatrics Corp. has expanded its product portfolio and increased its market share. He has overseen the launch of several new products and has led the company's efforts to expand into new geographic markets. His strategic decisions have positioned OrthoPediatrics as a key player in the pediatric orthopedic market. He manages 562 employees.
What Investors Ask About OrthoPediatrics Corp. (KIDS) — Healthcare
What does OrthoPediatrics Corp. do?
OrthoPediatrics Corp. is a medical device company focused on designing, developing, and marketing orthopedic implants and devices specifically for children. Unlike many larger medical device companies that adapt adult products for pediatric use, OrthoPediatrics is dedicated solely to addressing the unique anatomical and physiological needs of young patients. The company's product portfolio includes solutions for trauma, deformity correction, scoliosis, and sports medicine, serving pediatric orthopedic surgeons and caregivers in the United States and internationally. This specialization allows OrthoPediatrics to offer innovative and effective solutions tailored to the pediatric orthopedic market.
What do analysts say about KIDS stock?
Analyst consensus on OrthoPediatrics Corp. (KIDS) reflects a generally positive outlook, driven by the company's specialized focus on the pediatric orthopedic market and its potential for growth. Key valuation metrics, such as price-to-sales ratio, are often considered in relation to the company's growth prospects. Analysts typically highlight the company's innovative product portfolio and its ability to address unmet needs in pediatric orthopedics as key growth drivers. However, potential risks such as competition from larger medical device companies and regulatory challenges are also considered. The consensus is a neutral summary of analyst expectations.
What are the main risks for KIDS?
OrthoPediatrics faces several risks inherent to the medical device industry and its specific market focus. Competition from larger medical device companies with greater resources poses a significant threat. Regulatory hurdles and product approval delays can impact the company's ability to bring new products to market. Product liability claims related to orthopedic implants are also a concern. Additionally, economic downturns can affect hospital budgets and patient spending, potentially reducing demand for the company's products. Managing these risks effectively is crucial for OrthoPediatrics' long-term success.
What are the key factors to evaluate for KIDS?
OrthoPediatrics Corp. (KIDS) holds an AI score of 36/100 (low). Analysts target $25.00 (+23%). Not financial advice.
How frequently does KIDS data refresh on this page?
KIDS prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven KIDS's recent stock price performance?
OrthoPediatrics Corp. (KIDS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on a niche market with unmet needs. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider KIDS overvalued or undervalued right now?
Valuing OrthoPediatrics Corp. (KIDS) requires multiple metrics. Analysts target $25.00 (+23%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying KIDS?
Before investing in OrthoPediatrics Corp. (KIDS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Financial metrics are as of the latest reporting period.
- Analyst opinions may vary.